Similar articles

• Are we ready to use an early alternative end point as the primary end point of a phase III study in rectal cancer?

  Glynne-Jones R, Sebag-Montefiore D. Glynne-Jones R, et al. J Clin Oncol. 2010 Oct 10;28(29):e579-80; author reply e581-3. doi: 10.1200/JCO.2010.30.2067. Epub 2010 Aug 23. J Clin Oncol. 2010. PMID: 20733130 No abstract available.
• Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.

  Glynne-Jones R, Meadows H, Wood W. Glynne-Jones R, et al. Clin Oncol (R Coll Radiol). 2007 Jun;19(5):327-9. doi: 10.1016/j.clon.2007.03.003. Epub 2007 Apr 16. Clin Oncol (R Coll Radiol). 2007. PMID: 17434299 No abstract available.
• Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.

  Allegra CJ, Yothers G, O'Connell MJ, Beart RW, Wozniak TF, Pitot HC, Shields AF, Landry JC, Ryan DP, Arora A, Evans LS, Bahary N, Soori G, Eakle JF, Robertson JM, Moore DF Jr, Mullane MR, Marchello BT, Ward PJ, Sharif S, Roh MS, Wolmark N. Allegra CJ, et al. J Natl Cancer Inst. 2015 Sep 14;107(11):djv248. doi: 10.1093/jnci/djv248. Print 2015 Nov. J Natl Cancer Inst. 2015. PMID: 26374429 Free PMC article. Clinical Trial.
• Combined modality treatment for rectal cancer.

  Zhu AX, Willett CG. Zhu AX, et al. Semin Oncol. 2005 Feb;32(1):103-12. doi: 10.1053/j.seminoncol.2004.09.032. Semin Oncol. 2005. PMID: 15726512 Review.
• [Chemotherapy and rectal cancer].

  Michel P, Di Fiore F. Michel P, et al. Cancer Radiother. 2011 Oct;15(6-7):436-9. doi: 10.1016/j.canrad.2011.06.002. Epub 2011 Aug 31. Cancer Radiother. 2011. PMID: 21885319 Review. French.